Prilosec OTC Leads Stomach Remedy Market; Consumer Use Data Published
This article was originally published in The Tan Sheet
Executive Summary
Prilosec OTC leads the nonprescription stomach remedy market in food and drug channels with a 17% dollar share after roughly three months on the market, based on AC Nielsen data, Procter & Gamble said
You may also be interested in...
Mylan Says OTC, Rx Prilosec Not Bioequivalent In Study
Prilosec OTC is not bioequivalent to prescription Prilosec under the conditions of a small clinical study recently submitted to FDA by Mylan Labs, according to the firm
Mylan Says OTC, Rx Prilosec Not Bioequivalent In Study
Prilosec OTC is not bioequivalent to prescription Prilosec under the conditions of a small clinical study recently submitted to FDA by Mylan Labs, according to the firm
Mylan Says OTC, Rx Prilosec Not Bioequivalent In Study
Prilosec OTC is not bioequivalent to prescription Prilosec under the conditions of a small clinical study recently submitted to FDA by Mylan Labs, according to the firm